Author

M. Barz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

A. Best· 1 shared A. Corman· 1 shared A. K. Bergmann· 1 shared A. M. Hartmann· 1 shared A. M. Thompson· 1 shared B. Porebski· 1 shared B.-T. Hansen· 1 shared C. D. Baldus· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Best

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Discovery of a novel inhibitor of macropinocytosis with antiviral activity

B. Porebski, W. Christ, A. Corman, M. Haraldsson, M. Barz, L. Lidemalm, M. Haggblad, J. Illmain, S. Wright, M. Murga, J. Schlegel, E. Sezgin, G. Bhabha, V. M. Lauschke, M. Lafarga, , O. Fernandez-Capetillo

This study identifies virapinib, a novel inhibitor of macropinocytosis that blocks viral entry by SARS-CoV-2, Monkeypox virus, and TBEV without host cell toxicity.

bioRxiv · Oct 25, 2023Pharmacology & Toxicology

The gene expression classifier ALLCatchR identifies B-precursor ALL subtypes and underlying developmental trajectories across age

T. Beder, B.-T. Hansen, A. M. Hartmann, J. Zimmermann, E. Amelunxen, N. Wolgast, W. Walter, M. Zaliova, Z. Antic, P. Chouvarine, L. Bartsch, M. Barz, M. Bultmann, J. Horns, S. Bendig, , L. Bastian

ALLCatchR, a machine learning classifier, accurately assigns B-precursor ALL samples to molecular subtypes and identifies developmental trajectories using RNA-Seq data.

bioRxiv · Feb 1, 2023 · PreprintCancer Biology

{Pi}-{Pi} Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives Leading to Promising Therapy Against Tuberculosis in Zebrafish and Mouse Models

N.-J. K. Dal, G. Schafer, A. M. Thompson, S. Schmitt, N. Redinger, N. Alonso-Rodriguez, K. Johann, J. Ojong, J. Wohlmann, A. Best, K. Koynov, R. Zentel, U. E. Shaible, G. Griffiths, M. Barz, F. Fenaroli

This paper develops PeptoMicelle-based formulations of pretomanid derivatives using π-π interactions, showing improved efficacy against tuberculosis in zebrafish and mouse models.

bioRxiv · Mar 10, 2022Bioengineering